Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Bushen Yiqi Formula Combined With Dehydroepiandrosterone in Women With Diminished Ovarian Reserve [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating Bushen Yiqi Formula in combination with Dehydroepiandrosterone (DHEA) for women with diminished ovarian reserve; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bushen Yiqi Formula
  • Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: Jiangxi University of Traditional Chinese Medicine | Conditions: Diminished Ovarian Reserve | Phase 1, Phase 2 | Status: RECRUITING